Product Information
FEVERALL 325 MG SUPPOSITORY is a brand product labeled by Sun Pharmaceutical Industries Inc., priced at $0.9558 per EA under NDC 51672211602. Its NADAC has been published 338 times since Feb 18, 2015.
FDA first approved this application before 1982.
The High Outlier badge above means this manufacturer's average price in the Acetaminophen market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
325 mg/1
Manufacturer
Sun Pharmaceutical Industries Inc.NDC
51672211602
Classification
Brand
Dosage Form
SUPPOSITORY
Route
RECTAL
Effective Date
9/23/2026
Active Ingredients
ACETAMINOPHENApproval Type
New Drug (NDA)
FDA Application
NDA018337FDA Approved
Before 1982
On Market Since
12/12/2013
Price Statistics
The NADAC for FEVERALL 325 MG SUPPOSITORY has been published 338 times since Feb 18, 2015, and over the history we have for it it has risen 20.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.9558 per EA |
|---|---|
| All-time high | $0.9959 (Jan 14, 2026) |
| All-time low | $0.6730 (Sep 18, 2024) |
| 52-week high | $0.9959 |
| 52-week low | $0.8341 |
| Median price | $0.6986 |
| Average price | $0.7866 |
| Largest weekly change | +45.2% (Oct 2, 2024) |
| Weeks tracked | 338 |
| Tracking since | Feb 18, 2015 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 27% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Sun Pharmaceutical Industries Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Acetaminophen market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FEVERALL 325 MG SUPPOSITORY?
The current National Average Drug Acquisition Cost (NADAC) for FEVERALL 325 MG SUPPOSITORY, manufactured by Sun Pharmaceutical Industries Inc., is $0.9558 per EA (NDC 51672211602), effective Sep 30, 2026.
How has the price of FEVERALL 325 MG SUPPOSITORY changed over time?
Over the history we have for it, the NADAC for FEVERALL 325 MG SUPPOSITORY has risen 20.9%. It has been tracked across 338 weekly CMS publications since Feb 18, 2015.
What are the highest and lowest recorded NADAC prices for FEVERALL 325 MG SUPPOSITORY?
Since Feb 18, 2015, the NADAC for FEVERALL 325 MG SUPPOSITORY has ranged from a low of $0.6730 (Sep 18, 2024) to a high of $0.9959 (Jan 14, 2026), with a median of $0.6986 per EA.
Are there cheaper alternatives to FEVERALL 325 MG SUPPOSITORY?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, FEVERALL 325 MG SUPPOSITORY, is $0.6986 per EA — about 27% below FEVERALL 325 MG SUPPOSITORY.
Who manufactures FEVERALL 325 MG SUPPOSITORY?
FEVERALL 325 MG SUPPOSITORY (NDC 51672211602) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a brand product.